Piper Sandler raised the firm’s price target on CME Group (CME) to $283 from $275 and keeps an Overweight rating on the shares. The firm says strong Q1 2025 results and favorable macro setup should drive continued outperformance for exchange and trading company stocks; eBrokers beholden to retail resilience.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME: